Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 199,223 | 175,375 | 161,388 | 144,866 | 132,099 |
| Cost of Goods | 20,405 | 15,304 | 11,354 | 9,900 | 10,702 |
| Gross Profit | 178,818 | 160,071 | 150,034 | 134,966 | 121,397 |
| Operating Expenses | 208,420 | 199,224 | 178,111 | 156,818 | 156,196 |
| Operating Income | -29,197 | -38,849 | -27,723 | -20,952 | -34,097 |
| Other Income | 11,995 | 12,899 | 11,560 | 6,064 | 5,966 |
| Pre-tax Income | -17,202 | -25,950 | -16,163 | -14,888 | -28,131 |
| Income Tax | -317 | 374 | 57 | 359 | 448 |
| Net Income Continuous | -16,885 | -26,324 | -16,220 | -15,247 | -28,579 |
| Net Income | $-16,885 | $-26,324 | $-16,220 | $-15,247 | $-28,579 |
| EPS Basic Total Ops | -0.15 | -0.25 | -0.16 | -0.16 | -0.30 |
| EPS Basic Continuous Ops | -0.16 | -0.25 | -0.16 | -0.16 | -0.30 |
| EPS Diluted Total Ops | -0.15 | -0.25 | -0.16 | -0.16 | -0.30 |
| EPS Diluted Continuous Ops | -0.16 | -0.25 | -0.16 | -0.16 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.16 | -0.25 | -0.16 | -0.16 | -0.30 |
| EBITDA(a) | $-32,074 | $-40,558 | $-29,447 | $-23,163 | $-36,500 |